SCHEMBL2947428

SCHEMBL2947428

CCCCN(CCCC)c1ccc(C=CC=CC=Cc2cc[n+](CCCCS(=O)(=O)O)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.55
CHRM4 P08173 2/20 0.55
CHRM5 P08912 2/20 0.55
CHRM1 P11229 2/20 0.55
CHRM3 P20309 2/20 0.55
KDM4A O75164 4/20 0.48
KDM2A Q9Y2K7 4/20 0.48
INSR P06213 2/20 0.42
ATG4B Q9Y4P1 1/20 0.38
MEN1 O00255 2/20 0.36
APAF1 O14727 2/20 0.36
HSP90AA1 P07900 2/20 0.36
MAPK1 P28482 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 2/20 0.36
MAPT P10636 1/20 0.36
BLM P54132 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RGS12 O14924 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6283006 1.00 CHRM2 (0.55) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL455655 0.96 CHRM2 (0.52) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL455654 0.96 CHRM2 (0.52) CHRM2CHRM4CHRM5CHRM1CHRM3
Water SCHEMBL16343174 0.94 CHRM2 (0.51) CHRM2CHRM4CHRM5CHRM1CHRM3
Water SCHEMBL15128891 0.94 CHRM2 (0.51) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL13629539 0.94 CHRM2 (0.61) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL18102248 0.91 CHRM2 (0.52) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26644133 0.91 CHRM2 (0.62) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL14984184 0.90 KDM4A (0.58) CHRM2CHRM4CHRM5CHRM1CHRM3
Water SCHEMBL7040802 0.90 CHRM2 (0.61) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260124324-A1 PHOTOCLICK CHEMISTRY OF SILK FOR TEMPORARY UV TATTOOS TUFTS COLLEGE (US) 2026-05-07 US disclosed
EP-4734896-A2 BIOPOLYMER-BASED TYMPANOSTOMY TUBES WITH PROGRAMMABLE, TUNABLE, AND ON-DEMAND DEGRADATION Trustees Of Tufts College (US) 2026-05-06 EP disclosed
EP-4735018-A2 CENTRIFUGALLY-MOLDED ARTICLES AND METHODS Trustees Of Tufts College (US) 2026-05-06 EP disclosed
US-20260114758-A1 PAPER-BASED WEARABLE PATCHES FOR REAL-TIME, QUANTITATIVE LACTATE MONITORING Trustees of Tuffs College (US) 2026-04-30 US disclosed
EP-4705404-A2 SILK-BASED ADHESIVE PLATFORM FOR FOOTWEAR AND FASHION Trustees Of Tufts College (US) 2026-03-11 EP disclosed
EP-4661753-A2 PAPER-BASED WEARABLE PATCHES FOR REAL-TIME, QUANTITATIVE LACTATE MONITORING Trustees Of Tufts College (US) 2025-12-17 EP disclosed
WO-2025227091-A1 IMPROVED WHIPPED SILK CREAMS AND METHODS OF MAKING AND USING THE SAME TRUSTEES OF TUFTS COLLEGE (US) 2025-10-30 WO disclosed
US-20250325495-A1 SILK NANOPARTICLE SYNTHESIS: TUNING SIZE, DISPERSITY, AND SURFACE CHEMISTRY FOR DRUG DELIVERY TUFTS COLLEGE (US) 2025-10-23 US disclosed
WO-2025217387-A1 SILK COATING OF MUSICAL INSTRUMENTS AND MUSICAL INSTRUMENT COMPONENTS AND ACCESSORIES TRUSTEES OF TUFTS COLLEGE (US) 2025-10-16 WO disclosed
US-12332180-B2 Antimicrobial surface coating formation, detection, quantification and reactivation systems and methods B/E AEROSPACE, INC. (US) 2025-06-17 US disclosed
WO-2009114133-A1 CELLS AND ASSAYS FOR USE IN DETECTING LONG QT SYNDROME THE J. DAVID GLADSTONE INSTITUTES (US) 2009-09-17 WO disclosed
US-20090227469-A1 CELLS AND ASSAYS FOR USE IN DETECTING LONG QT SYNDROME THE J. DAVID GLADSTONE INSTITUTES 2009-09-10 US disclosed
US-20080182289-A1 High-Throughput Screen For Identifying Selective Persistent Sodium Channels Channel Blockers ALLERGAN, INC. 2008-07-31 US disclosed
US-20080182288-A1 High-Throughput Screen For Identifying Selective Persistent Sodium Channels Channel Blockers ALLERGAN, INC. 2008-07-31 US disclosed
US-7361478-B2 High-throughput screen for identifying selective persistent sodium channels channel blockers ALLERGAN, INC. (US) 2008-04-22 US disclosed
US-20060110778-A1 High-throughput screen for identifying selective persistent sodium channels channel blockers ALLERGAN, INC. 2006-05-25 US disclosed
US-6869772-B2 Method for labeling individual cells WASHINGTON UNIVERSITY (US) 2005-03-22 US disclosed
EP-1259808-A2 METHOD FOR LABELING INDIVIDUAL CELLS WASHINGTON UNIVERSITY (US) 2002-11-27 EP disclosed
US-20020155520-A9 Method for labeling individual cells WASHINGTON UNIVERSITY 2002-10-24 US disclosed
WO-2001069244-A2 METHOD FOR LABELING INDIVIDUAL CELLS WASHINGTON UNIVERSITY (US) 2001-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260114758-A1 PAPER-BASED WEARABLE PATCHES FOR REAL-TIME, QUANTITATIVE LACTATE MONITORING LDHB, LDHA, LPO CHRM2 533/4885CHRM4 497/4885CHRM5 1095/4885
US-20260124324-A1 PHOTOCLICK CHEMISTRY OF SILK FOR TEMPORARY UV TATTOOS PTMS, ITK, MATK CHRM2 3100/4885CHRM4 3507/4885CHRM5 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.